|
Call 1-877-331-2545 Anytime To Discuss Treatment Options |
October 2, 2004Abilify approved for Bipolar Disorder Maniafiled under
Bipolar Disorder Complimentary Treatments
Bristol-Myers Squibb (bmy) and partner Otsuka Pharmaceutical received approval of Abilify, a drug for the treatment of acute bipolar mania, from the Food and Drug Administration. Abilify was previously approved in 2002 by the FDA to treat schizophrenia. Posted by szadmin at October 2, 2004 8:02 AM
More Information on Bipolar Disorder Complimentary Treatments Comments
(4) comments have been posted! Click here to read them...
Post a comment |
|